Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26
Welcure Drugs & Pharmaceuticals Ltd · Outcome · 30 May 2026, 1:31 am
Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) ■ Revenue: 0.0 (-100.0% YoY) ■ EBITDA: -4,986 (Profit to Loss YoY | -147856.7% QoQ) ■ EBITDA Margin (%): 0.0 (-300 bps YoY) ■ PAT: -4,986 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -0.40 (Profit to Loss YoY | Profit to Loss QoQ) Welcure Drugs & Pharmaceuticals Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lacs) Segmental Performance Agriculture ■ Revenue: 0.0 (-100.0% YoY | -100.0% QoQ) ■ EBITDA: -4,986 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): 0.0 (-1099 bps YoY | -9736 bps QoQ) Drugs and Pharmaceuticals ■ Revenue: 0.0 ■ EBITDA: 0.0 ■ EBITDA Margin (%): 0.0
Original exchange filing (PDF)
More announcements from Welcure Drugs & Pharmaceuticals Ltd
- Approval of the Audited Standalone Financial Results and Audited Standalone Financial Statements · 02 Nov 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Ltd held on today i.e. Tuesday, 14th July, 2026. · 14 Jul 2026
- Resignation of Company Secretary and Compliance Officer · 19 Jun 2026
- Outcome of the Meeting of the Board of Directors of Welcure Drugs & Pharmaceuticals Limited held on Today i.e. Friday, 19th June, 2026 · 19 Jun 2026
- Audited Standalone Financial Results for the Quarter and Year Ended 31st March, 2026 · 30 May 2026
- Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial .... · 29 May 2026
- <b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> .... · 23 Apr 2026
- Unaudited Financials Results for the 3rd Quarter ended on 31st December, 2025 · 13 Feb 2026
